   |
|
SHORT COMMUNICATION |
|
| Year : 2016 | Volume
: 61
| Issue : 5 | Page : 561-564 |
|
| Inpatient dermatology: Characteristics of patients and admissions in a tertiary level hospital in Eastern India |
|
|
Arpita Sen, Satyendranath Chowdhury, Indrasish Poddar, Debabrata Bandyopadhyay
Department of Dermatology, Venereology and Leprosy, Medical College and Hospital, Kolkata, West Bengal, India
| Date of Web Publication | 9-Sep-2016 |
Correspondence Address:
Debabrata Bandyopadhyay
Department of Dermatology, Venereology and Leprosy, Medical College and Hospital, 88, College Street, Kolkata - 700 073, West Bengal
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0019-5154.190104
|
|
 Abstract | | |
Introduction: Dermatology is primarily a non-acute, outpatient-centered clinical specialty, but substantial number of patients need indoor admission for adequate management. Over the years, the need for inpatient facilities in Dermatology has grown manifold; however, these facilities are available only in some tertiary centers. Aims and Objectives: To analyze the characteristics of the diseases and outcomes of patients admitted in the dermatology inpatient Department of a tertiary care facility in eastern India. Materials and Methods: We undertook a retrospective analysis of the admission and discharge records of all patients, collected from the medical records department, admitted to our indoor facility from 2011 to 2014. The data thus obtained was statistically analyzed with special emphasis on the patient's demographic profile, clinical diagnosis, final outcome, and duration of stay. Results and Analysis: A total of 375 patients were admitted to our indoor facility during the period. Males outnumbered females, with the median age in the 5th decade. Immunobullous disorders (91 patients, 24.27%) were the most frequent reason for admissions, followed by various causes of erythroderma (80 patients, 21.33%) and infective disorders (73 patients, 19.47%). Other notable causes included cutaneous adverse drug reactions, psoriasis, vasculitis, and connective tissue diseases. The mean duration of hospital stay was 22.2±15.7 days; ranging from 1 to 164 days. Majority of patients (312, 83.2%) improved after hospitalization; while 29 (7.73%) patients died from their illness. About 133 patients (35.64%) required referral services during their stay, while 8 patients (2.13%) were transferred to other departments for suitable management. Conclusion: Many dermatoses require inpatient care for their optimum management. Dermatology inpatient services should be expanded in India to cater for the large number of cases with potentially highly severe dermatoses.
Keywords: Admission, dermatology, India, inpatient
How to cite this article:
Sen A, Chowdhury S, Poddar I, Bandyopadhyay D. Inpatient dermatology: Characteristics of patients and admissions in a tertiary level hospital in Eastern India. Indian J Dermatol 2016;61:561-4 |
How to cite this URL:
Sen A, Chowdhury S, Poddar I, Bandyopadhyay D. Inpatient dermatology: Characteristics of patients and admissions in a tertiary level hospital in Eastern India. Indian J Dermatol [serial online] 2016 [cited 2023 Sep 28];61:561-4. Available from: https://www.e-ijd.org/text.asp?2016/61/5/561/190104 |
What was known?
Several dermatological conditions are severe enough to merit inpatient admission for proper investigation and management. The relative frequency of different diseases requiring inpatient care may vary in different geographic regions.
| Introduction | |  |
Dermatology is primarily an outpatient-oriented specialty, most of the skin diseases being associated with variable morbidity but low mortality. However, there are several dermatological disorders which are severe enough to mandate inpatient admission. There are several ways in which these patients may benefit from hospital admission. Seriously ill patients may need regular clinical and laboratory monitoring, parenteral therapies, advanced nursing care and multispecialty referral for their condition which is only possible in an inpatient setting. Absence of domestic pressures and opportunities for the patients for gaining skills needed to manage their condition themselves in future are additional advantages.[1] There is evidence for significant improvement in measures of quality of life, depression, and anxiety following hospitalization for skin disease.[2],[3] Till date, most of the studies concerning dermatology inpatient admissions hail from the western world, where psoriasis, bullous disorders, chronic ulcers, and dermatitis constitute about 70% of the inpatients.[4],[5],[6] In comparison, immunobullous disorders, infections, and drug reactions are the most common causes of inpatient admissions in this part of the globe.[7],[8],[9] We undertook this study to ascertain the characteristics of indoor admissions and the patterns of disease and their outcome at a tertiary care center in eastern India. Dearth of studies addressing inpatient dermatology in India has prompted us to embark on this work.
| Materials and Methods | | |
We conducted a retrospective analysis of admissions and discharge records of all patients admitted during 2011–2014. The data obtained were analyzed statistically focusing mainly on the demographic profile of patients, clinical diagnosis, type of complications, referrals made to other departments, duration of hospital stay, mortality, and final condition of patient at the time of discharge. All the data have been preserved for future reference.
| Results and Analysis | | |
A total of 375 patients were admitted under our departmental care from 2011 to 2014. The major reasons for admission were severe disease with potential mortality, lack of response to outpatient management, and need for nursing care.
Demographics
In our study, male patients (62.2%) outnumbered female patients (37.5%). The mean age was calculated to be 45.5 ± 2 years, ranging from 6 to 90 years. Most patients came from the city of Kolkata and the adjoining rural districts.
Clinical diagnoses
Diagnoses were assigned to one of the following ten categories: Immunobullous disorders, psoriasis, erythroderma, infections, cutaneous adverse drug reactions, eczema/dermatitis, vasculitis, connective tissue disorders, malignancies, and miscellaneous dermatoses. Immunobullous disorders (91 cases, 24.27%) comprised the most frequent cause of admission followed by various causes of erythroderma (80 cases, 21.33%) and different infective disorders (73 cases, 19.47%). Pemphigus vulgaris, bullous pemphigoid, and pemphigus foliaceus were the most common immunobullous disorders (in order). About 40% of the cases of erythroderma were idiopathic in nature. Leprosy (43 patients) comprised 59% of the infectious disease group followed by postkala azar dermal leishmaniasis (PKDL) (27 patients, 37%). Remainder of the infectious diseases group consisted of 2 patients of severe cellulitis and one patient of rhinoscleroma. Almost all leprosy patients (40) were admitted for reactions (Type 2 > Type 1). Three patients were admitted for multidisciplinary management of trophic ulcers. PKDL patients were admitted for detailed evaluation and administration of liposomal amphotericin B. The mean duration of stays for leprosy and PKDL patients were 21.3 days and 22.4 days, respectively. All the clinical diagnostic groups along with percentage of patients affected are tabulated [Table 1]. | Table 1: Clinical diagnoses with percentage of patients affected (n=375)
Click here to view |
Complications and referrals
About 25.5% of our patients developed at least one complication during their hospital stay, while 133 (35.46%) patients had to be referred to other departments for their optimum management [Table 2]. | Table 2: Percentage of patients requiring referral to other departments (nũ133)
Click here to view |
Final outcome
The final outcome following hospital stay was satisfactory; majority of the patients improved, and they have been advised regular follow-up at our outpatient department (312, 83.2%); 19 (5.07%) patients left against medical advice, 8 (2.13%) patients had to be transferred out to ICU and other departments for effective management. Despite our best efforts, 29 (7.46%) patients died. Highest mortality (17, 58.62%) occurred in patients suffering from immunobullous disorders. Septicemia was the leading cause of death (13 patients, 44.83%) overall. The cause of death and the final diagnoses of deceased patients are shown in [Table 3]. | Table 3: Mean length of stay, referral and mortality rates of different diagnostic categories
Click here to view |
Duration of stay in hospital
The duration of hospital stay ranged from 1 day to 164 days; the mean duration being 22.16 ± 15.73 days. The duration of stay along with the referral and mortality rates of patients belonging to different diagnostic categories has been tabulated [Table 4]. | Table 4: Cause of death and final clinical diagnosis at the time of death (n=29)
Click here to view |
| Discussion | | |
We analyzed the records of 375 patients, spanning over 4 years (2011–2014). The majority (62%) of our patients were males, who were mostly in their fifth decade. Similar male preponderance was noted in an Australian study,[10] while a Nepalese study [7] showed female preponderance. The mean age of our patients (45.5) was similar to the findings reported from Iran (44 years),[9] whereas it was higher when compared to the findings of studies from Nepal (35.5 years)[7] and South Africa (34.1 years).[11] Where as a higher mean age of about 53 years, was reported from greater Manchester, UK.[12]
The most common cause of admission in our study was immunobullous disorders (91 patients, 24.27%), followed by various causes of erythroderma (80 patients. 21.33%) and different infective disorders (73 patients, 19.47%). Pemphigus vulgaris was the most common immune-bullous disorder, accounting for almost 46% of the cases of this group. Bullous pemphigoid and pemphigus foliaceus were the other two notable immune-bullous disorders. Immunobullous disorders was also the most common cause of admission in Iran [9] and fourth most common cause in the USA;[13] however, it was pretty uncommon in a Spanish hospital.[14] Erythroderma was the second most common cause of admission in our study. Psoriasis and dermatitis accounted for most of these cases. Infections were the third most common cause of admission in our series (19.47%). Leprosy, mainly reactional forms, was the most frequent infective disorder, followed by PKDL. Infective conditions were the most frequent cause of indoor admission in Pakistan,[8] while those accounted for 15.9% of admissions in Brazil;[1] 8.3% of admissions in Nepal,[7] and 3.74% in Iran.[9] Cutaneous adverse drug reactions (Stevens–Johnson syndrome - toxic epidermal necrolysis [TEN], drug hypersensitivity syndrome, exanthematous reaction) accounted for 10.67% of admission in our study whereas it was most important cause of admission at Nepal (21.6%).[7] While psoriasis, dermatitis, skin cancers, and leg ulcers comprised the most common causes of admission in western countries,[14] these conditions accounted for lesser number of admissions in our study. Our findings are shown in [Table 1].
About 25.5% of our patients developed some form of complications during their hospital stay, while 35.6% of our patients had to be referred to at least one specialist department for management of their disease complications and comorbidities. This rate of referral is much lower than that reported by an Australian study (92%).[10] Most referrals were made to the department of internal medicine (48.87%) followed by the department of ophthalmology (20.30%) [Table 2].
The mean duration of hospital stays for our patients ranged from 1 to 164 days (mean 22.16 ± 15.7). The details are shown in [Table 3]. About 107 patients (28.55%) stayed for <2 weeks, while 92 patients (24.5%) had to stay for more than a month. The mean duration of hospital stay was much higher when compared to the inpatients of Brazil (13 days),[11] Australia (10 days),[11] and the USA.[13] The longer duration of stay for our patients is mainly explained by the most frequent reasons of admission: Immunobullous diseases and erythroderma, conditions requiring a relatively long duration of treatment for induction of remission or significant improvement.
Overall, the outcome of admitted patients was satisfactory, the mortality rate being 7.73% (29 patients) [Table 4]. An Indian study specifically looking into the mortality in dermatology inpatients had recorded a mortality rate of 3.8%.[15] Majority of the cases were accounted for by immunobullous disorders and TEN. The death rate among our patients was highest among patients with immunobullous disorders (58.62%) followed by drug reactions and different forms of erythroderma (17.24% each). The most common cause of death was found to be septicemia (44.83%) followed by cardiorespiratory complications (41.38%) and renal impairment (13.79%). Advanced stage of disease at the time of admission and multiple comorbidities probably accounted for this high mortality rate in these patients. Most (83.2%) patients benefitted from inpatient care and they were advised regular outpatient follow-up, while 8 (2.13%) patients had to be transferred to other departments for their co-morbidities. These figures are comparable to previous studies.[7],[12]
| Conclusion | | |
Patients with several dermatological conditions require inpatient admission for severity of their disease and comorbidities. The conditions requiring admission vary from one geographic region to another. Since many of the diseases are chronic in nature, they may require prolonged hospital stay. Most of the admitted patients can benefit from inpatient care. Thus, there is a need for expansion of specialized dermatological inpatient facilities.
Financial support and sponsorship
Nil.
Conflflicts of interest
There are no conflicts of interest.
| References | | |
| 1. | de Paula Samorano-Lima L, Quitério LM, Sanches JA Jr., Neto CF. Inpatient dermatology: Profile of patients and characteristics of admissions to a tertiary dermatology inpatient unit in São Paulo, Brazil. Int J Dermatol 2014;53:685-91.  |
| 2. | Kurwa HA, Finlay AY. Dermatology in-patient management greatly improves life quality. Br J Dermatol 1995;133:575-8. |
| 3. | Hurwitz D, Kerdel FA, Kirsner RS. Hospitalization for skin disease improves quality of life. Arch Dermatol 1997;133:797-8. |
| 4. | Ayyalaraju RS, Finlay AY. Inpatient dermatology. United Kingdom and United States similarities: Moving with the times or being relegated to the back bench? Dermatol Clin 2000;18:397-404, vii-viii. |
| 5. | Ferguson JA, Goldacre MJ, Newton JN, Dawber RP. An epidemiological profile of in-patient workload in dermatology. Clin Exp Dermatol 1992;17:407-12. |
| 6. | Munro CS, Lowe JG, McLoone P, White MI, Hunter JA. The value of in-patient dermatology: A survey of in-patients in Scotland and Northern England. Br J Dermatol 1999;140:474-9. |
| 7. | Parajuli S, Paudel U, Pokhrel DB. In patient dermatology: Characteristics of patients and admissions in Tribhuvan University (TU) Teaching Hospital. Nepal J Dermatol Venereol Leprol 2013;11:59-63. |
| 8. | Raza N, Saleem J, Rashid Dar N, Malik NA. Why dermatology patients are hospitalized? A study from Pakistan. Acta Dermatovenerol Croat 2009;17:113-7. |
| 9. | Hasan S, Farshad F, Negin S, Parastoo D, Farzam G. Patterns of admissions to a Referral Skin Hospital in Iran. Iran J Dermatol 2008;11:156-8. |
| 10. | Bale J, Chee P. Inpatient dermatology: Pattern of admissions and patients' characteristics in an Australian hospital. Australas J Dermatol 2014;55:191-5. |
| 11. | Jessop S, McKenzie R, Milne J, Rapp S, Sobey G. Pattern of admissions to a tertiary dermatology unit in South Africa. Int J Dermatol 2002;41:568-70. |
| 12. | Helbling I, Muston HL, Ferguson JE, McKenna M. Audit of admissions to dermatology beds in Greater Manchester. Clin Exp Dermatol 2002;27:519-22. |
| 13. | Ayyalaraju RS, Finlay AY, Dykes PJ, Trent JT, Kirsner RS, Kerdel FA. Hospitalization for severe skin disease improves quality of life in the United Kingdom and the United States: A comparative study. J Am Acad Dermatol 2003;49:249-54. |
| 14. | García-Doval I, Feal C, Rosón E, de la Torre C, Abalde MT, Flórez A, et al. Inpatient dermatology: Characteristics of patients and admissions in a Spanish hospital. J Eur Acad Dermatol Venereol 2002;16:334-8. |
| 15. | Nair PS, Moorthy PK, Yogiragan K. A study of mortality in dermatology. Indian J Dermatol Venereol Leprol 2005;71:23-5. [ PUBMED]  |
What is new?
Immunobullous disorders, erythroderma, and infections were the most frequent conditions requiring inpatient care in our patients. About one-third of the patients needed referral to other departments. While there were some mortalities, the majority of the patients significantly benefitted from indoor treatment.
[Table 1], [Table 2], [Table 3], [Table 4] |
|
| This article has been cited by | | 1 |
Generalized pustular psoriasis in Brazil: A public claims database study |
|
| Gleison Vieira Duarte, André Vicente Esteves de Carvalho, Ricardo Romiti, Antonio Gaspar, Thaís Gomes de Melo, Cinara Prata Soares, Anna Rita Aguirre | | JAAD International. 2022; 6: 61 | | [Pubmed] | [DOI] | | | 2 |
An Australian tertiary hospital analysis of outpatient dermatology clinical and demographic characteristics |
|
| Harrison A. Edwards, Brigid Betz-Stablein, Anna Finnane, Xiaohua Shen, Hans Peter Soyer, Lisa Hall | | Australasian Journal of Dermatology. 2021; 62(4) | | [Pubmed] | [DOI] | | | 3 |
Profile of dermatology inpatients and admissions over a four year period in a tertiary level government teaching hospital in North India |
|
| Vishal Gupta, Savera Gupta, Geetali Kharghoria, Mona Pathak, Vinod Kumar Sharma | | Indian Journal of Dermatology, Venereology and Leprology. 2021; 0: 1 | | [Pubmed] | [DOI] | | | 4 |
Profil Pemphigus Vulgaris di Instalasi Rawat Inap RSUD Dr. Moewardi Surakarta Periode Januari 2014-Desember 2019 |
|
| Eka Devinta Novi Diana, Wibisono Nugraha, Alfina Rahma, Frieda, Anindya Oktafiani, Rieska Widyaswari, Muhammad Eko Irawanto | | MEDICINUS. 2021; 34(3): 27 | | [Pubmed] | [DOI] | | | 5 |
Dermatologists’ perceptions of suicidality in dermatological practice: a survey of prevalence estimates and attitudes in Austria |
|
| Ekaterina Pronizius, Martin Voracek | | BMC Dermatology. 2020; 20(1) | | [Pubmed] | [DOI] | |
|
|
|
|
|
|
|
|
|
|
|
| Article Access Statistics | | | Viewed | 3835 | | | Printed | 114 | | | Emailed | 0 | | | PDF Downloaded | 82 | | | Comments | [Add] | | | Cited by others | 5 | | |
|
|
